To assess the effect of NeuproGemp on spatial learning and memory in Alzheimer’s disease (AD) model mice, APP/PS1 transgenic mice aged 5 months were orally administered NeuproGemp (300 mg/kg/day) for 6 weeks. The gene discussed is PSEN1; the disease is early-onset autosomal dominant Alzheimer disease.